Outcomes of endoscopic submucosal dissection for gastric epithelial neoplasm in chronic kidney disease patients: propensity score-matched case –control analysis

ConclusionsESD for gastric epithelial neoplasms can be performed in stage 3 CKD patients with comparable efficacy and safety to that performed in non-CKD patients. Stage 4 and 5 CKD patients should be closely monitored for bleeding events after ESD.

http://link.springer.com/10.1007/s10120-018-0848-4

Source: Gastric Cancer - June 12, 2018 Category: Gastroenterology Source Type: research